Schuetz, M. et al. 2010. Evaluating repetitive 18F-fluoroazomycin-arabinoside (18FAZA) PET in the setting of MRI guided adaptive radiotherapy in cervical cancer. Acta Oncologica. 49, 7 (Oct. 2010), 941–947. DOI:https://doi.org/10.3109/0284186X.2010.510145.